NIM
NEOS Investment Management Portfolio holdings
AUM
$19.8B
1-Year Est. Return
31.12%
This Fund
S&P 500
1 Year Est. Return
+31.12%
AUM
$19.8B
AUM Growth
+$2.5B
(+14%)
Holding
664
Top Buys
| 1 | +$333M | |
| 2 | +$242M | |
| 3 | +$218M | |
| 4 |
Apple
AAPL
|
+$213M |
| 5 |
Microsoft
MSFT
|
+$176M |
Top Sells
| 1 | +$62.6M | |
| 2 | +$62.3M | |
| 3 | +$60.9M | |
| 4 |
Powell Industries
POWL
|
+$24.3M |
| 5 |
AstraZeneca
AZN
|
+$22.2M |
Sector Composition
| 1 | Technology | 38.36% |
| 2 | Communication Services | 12.13% |
| 3 | Consumer Discretionary | 10.25% |
| 4 | Healthcare | 6.37% |
| 5 | Consumer Staples | 6.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Icon
ICLR
$10.4B
| – | – |
-7,897
|
|
||
652
Idacorp
IDA
$7.77B
| – | – |
-79,408
|
|
||
653
IDEAYA Biosciences
IDYA
$2.59B
| – | – |
-71,178
|
|
||
654
Immunocore
IMCR
$1.47B
| – | – |
-22,599
|
|
||
655
Immunome
IMNM
$2.47B
| – | – |
-103,585
|
|
||
656
Ionis Pharmaceuticals
IONS
$12.6B
| – | – |
-8,557
|
|
||
657
Itron
ITRI
$3.66B
| – | – |
-96,566
|
|
||
658
Janux Therapeutics
JANX
$890M
| – | – |
-37,647
|
|
||
659
Legend Biotech
LEGN
$5.04B
| – | – |
-92,017
|
|
||
660
Lamb Weston
LW
$5.96B
| – | – |
-15,092
|
|
||
661
Masimo
MASI
$9.35B
| – | – |
-4,342
|
|
||
662
Madrigal Pharmaceuticals
MDGL
$11.5B
| – | – |
-1,571
|
|
||
663
Mirion Technologies
MIR
$4.47B
| – | – |
-104,962
|
|
||
664
Mineralys Therapeutics
MLYS
$2.6B
| – | – |
-6,463
|
|